🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hanfeng Lin

Baylor College of Medicine

ORCID: 0000-0002-3172-5616

Also affiliated with Baylor School, NewGen Therapeutics (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: Development of a RIPK1 degrader to enhance antitumor immunity.

26 citations

Dong Lu, Xiaoli Qi, Rishi R. Paudel, Hanfeng Lin, Bryan L. Holloman +8 more

21 citations

Liya Hu, Hanfeng Lin, Allison Judge, Paola Rivera, Murugesan Palaniappan +5 more

21 citations

Hanfeng Lin, Liya Hu, Neetu Neetu, Banumathi Sankaran, Jin Wang +3 more

N/A
0DataRank · unranked
0 citations

Jianwei Chen, Xiqian Jiang, Dong Lu, Xin Yu, Hanfeng Lin +4 more

10 citations

Hanfeng Lin, Bin Yang, Xiqian Jiang, Jianwei Chen, Sandipan Chowdhury +6 more

5 citations

Bin Yang, Lang Ding, Yen‐Yu Yang, Matthew V. Holt, Sung Yun Jung +4 more

21 citations

Wenhao Guo, Hanfeng Lin, Ran Cheng, Erika Y. Monroy, Feng Jin +6 more

3 citations

Xin Qi Yu, Hanfeng Lin, Ran Cheng, Bin Yang, Min Zhang +5 more